Veracyte revenue up 15% to $151.8 million
Veracyte grew Q3 2026 revenue 15% to $151.8 million and announced a $100 million share repurchase program, highlighting strong profitability and operational cash flow.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed